
The GLOW Analysis is a targeted laboratory test designed to confirm the identity and determine the amount of GHK or GHK-Cu, TB-500, and BPC-157 in a peptide blend.
The analysis is intended for lyophilised GLOW samples and is performed by HPLC, with results reported in milligrams per vial. Peptide purity cannot be determined in peptide blends because impurities from the individual components may overlap during analysis.
GHK is the tripeptide Gly-His-Lys, while GHK-Cu is its copper complex. Both have been investigated in connection with tissue remodeling and wound-healing processes.
TB-500 is a synthetic peptide related to an active region of thymosin β4, while BPC-157 is a synthetic pentadecapeptide investigated primarily in experimental models of tissue repair and regeneration.
Important Notice
- Peptide purity cannot be determined in this blend because impurities from the individual peptides may overlap and cannot be reliably distinguished from one another.
- This analysis is specifically intended for GLOW blends containing GHK or GHK-Cu, TB-500, and BPC-157. It does not automatically screen the sample for other peptides, related compounds, contaminants, or undeclared substances.
- For analysis, one whole unopened vial containing lyophilisate is required.
The following optional laboratory services are available:
